Trinity Biotech (TRIB) Profit After Tax Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Profit After Tax Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 2.68% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.79% |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.38% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 30.83% |
| 10 | Trinity Biotech | 111.52 Mn | 106.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -134.89% |
| Sep 30, 2024 | -76.79% |
| Jun 30, 2024 | -105.11% |
| Mar 31, 2024 | -34,955.13% |
| Dec 31, 2023 | -22,447.23% |
| Sep 30, 2023 | -42.89% |
| Jun 30, 2023 | -63,895.26% |
| Mar 31, 2023 | -38,935.50% |
| Dec 31, 2022 | -20,954.53% |
| Sep 30, 2022 | -215,257.26% |
| Jun 30, 2022 | -33,831.13% |
| Mar 31, 2022 | -109,234.83% |
| Dec 31, 2021 | 62.96% |
| Sep 30, 2021 | 46.88% |
| Jun 30, 2021 | -30,252.97% |
| Mar 31, 2021 | 62.33% |
| Dec 31, 2020 | 99.78% |
| Sep 30, 2020 | 126.79% |
| Jun 30, 2020 | -25.99% |
| Mar 31, 2020 | -57.31% |